Why COVID-19 trials should be blinded (as any other one)
DOI:
https://doi.org/10.17267/2675-021Xevidence.v2i1.2841Keywords:
Blinding. Clinical trials. COVID-19.Downloads
Download data is not yet available.
Downloads
Published
04/01/2020
Issue
Section
Concept Articles
License
The authors retain copyrights, transferring to the Journal of Evidence-Based Healthcare only the right of first publication. This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
Why COVID-19 trials should be blinded (as any other one). (2020). Journal of Evidence-Based Healthcare, 2(1), 25-27. https://doi.org/10.17267/2675-021Xevidence.v2i1.2841